# MRI in Predicting Tumor Reponse After Radiofrequency Ablation in Women With Invasive Breast Cancer

> **NCT00373152** · PHASE2 · WITHDRAWN · sponsor: **Masonic Cancer Center, University of Minnesota**

## Conditions studied

- Breast Cancer

## Interventions

- **PROCEDURE:** Lumpectomy
- **PROCEDURE:** dynamic contrast-enhanced magnetic resonance imaging
- **PROCEDURE:** radiofrequency ablation
- **RADIATION:** gadopentetate dimeglumine

## Key facts

- **NCT ID:** NCT00373152
- **Lead sponsor:** Masonic Cancer Center, University of Minnesota
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2005-03
- **Primary completion:** 2010-06
- **Final completion:** 2010-06
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** No patient accrual
- **Last updated:** 2017-12-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00373152

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00373152, "MRI in Predicting Tumor Reponse After Radiofrequency Ablation in Women With Invasive Breast Cancer". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00373152. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*